Why the study?
Surgical reparation for symptomatic paravalvular leak is based on non-randomized observational registries, while transcatheter closure has emerged as a first option in selected patients.
This review summarizes the clinical manifestations, diagnosis, and management of mitral paravalvular leak, highlighting transcatheter closure as an emerging alternative to surgery.
Paravalvular leak incidence after mitral surgical replacement ranges from 7% to 17%. Between 1% and 5% of these are clinically significant. Large PVLs can cause important clinical manifestations such as heart failure or haemolysis. Current guidelines consider that surgical reparation is the gold-standard therapy in symptomatic patients with paravalvular leak. However, these recommendations are based in non-randomized observational registries. On the other hand, transcatheter paravalvular leak closure has shown excellent results with a low rate of complications, and nowadays it is considered the first option in selected patients in some experienced centres. In this review, we summarize the clinical manifestations, diagnosis, procedural details, and results of transcatheter mitral PVL closure.
No takes yet. Share an insight, caveat, or question.
Cruz‐González et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: